On August 9, 2021 Herantis Pharma Plc ("Herantis or the Company"), focusing on disease modifying therapies for debilitating neurodegenerative diseases, reported that the company will report its half yearly financial report for the period January 1 – June 30, 2021 on Thursday, August 26th, 2021 at 9:00 EEST / 8:00 CEST (Press release, Herantis Pharma, AUG 9, 2021, View Source;2021,c3393805 [SID1234586138]). Investors, analysts and media are invited to a webcasted live call on the same day at 10:30 EEST / 9:30 CEST.To register for Herantis’ 1H 2021 Financial Report live call:Register Here: Herantis’ 1H 2021 Financial Report Live Call

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Webinar ID: 235-655-763

Questions can be submitted throughout the webcast event.

Following the webcast of the live call, a recording will be available on Herantis Pharma’s website (www.herantis.com).